Terms: = Bone cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Treatment
155 results:
1. Secondary peripheral chondrosarcoma in multiple osteochondromas: a retrospective single-institution case series.
Gnoli M; Gambarotti M; Righi A; Staals EL; Evangelista A; Tremosini M; Brizola E; Mordenti M; Boarini M; Locatelli M; Pedrini E; Sangiorgi L
Orphanet J Rare Dis; 2024 Feb; 19(1):63. PubMed ID: 38351015
[TBL] [Abstract] [Full Text] [Related]
2. Engineering alginate-based injectable hydrogels combined with bioactive polymers for targeted plasma-derived oxidative stress delivery in osteosarcoma therapy.
Espona-Noguera A; Tampieri F; Canal C
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128841. PubMed ID: 38104678
[TBL] [Abstract] [Full Text] [Related]
3. A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy.
Chen Z; Yang X; Chen Z; Li M; Wang W; Yang R; Wang Z; Ma Y; Xu Y; Ao S; Liang L; Cai C; Wang C; Deng T; Gu D; Zhou H; Zeng G
BMC Med; 2023 Oct; 21(1):402. PubMed ID: 37880708
[TBL] [Abstract] [Full Text] [Related]
4. Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection.
Liccardo F; Śniegocka M; Tito C; Iaiza A; Ottone T; Divona M; Travaglini S; Mattei M; Cicconi R; Miglietta S; Familiari G; Nottola SA; Petrozza V; Tamagnone L; Voso MT; Masciarelli S; Fazi F
J Exp Clin Cancer Res; 2023 Aug; 42(1):223. PubMed ID: 37653435
[TBL] [Abstract] [Full Text] [Related]
5. Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment.
Xu P; Yang JC; Chen B; Nip C; Van Dyke JE; Zhang X; Chen HW; Evans CP; Murphy WJ; Liu C
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37147019
[TBL] [Abstract] [Full Text] [Related]
6. Nanotherapeutic Approach to Delivery of Chemo- and Gene Therapy for Organ-Confined and Advanced Castration-Resistant Prostate cancer.
Sharma S; Mahajan SD; Chevli K; Schwartz SA; Aalinkeel R
Crit Rev Ther Drug Carrier Syst; 2023; 40(4):69-100. PubMed ID: 37075068
[TBL] [Abstract] [Full Text] [Related]
7. Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer.
Mateu-Sanz M; Ginebra MP; Tornín J; Canal C
Free Radic Biol Med; 2022 Aug; 189():32-41. PubMed ID: 35843475
[TBL] [Abstract] [Full Text] [Related]
8. Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression.
Ruchalski K; Kim HJ; Douek M; Raman S; Patel M; Sai V; Gutierrez A; Levine B; Fischer C; Allen-Auerbach M; Gupta P; Coy H; Villegas B; Brown M; Goldin J
Cancer Imaging; 2022 Jul; 22(1):34. PubMed ID: 35836271
[TBL] [Abstract] [Full Text] [Related]
9. Lack of association between dental implants and oral squamous cell carcinoma.
Afrashtehfar KI; Almomani MM; Momani M
Evid Based Dent; 2022 Mar; 23(1):40-42. PubMed ID: 35338331
[TBL] [Abstract] [Full Text] [Related]
10. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
; Bradbury CA; Lawler PR; Stanworth SJ; McVerry BJ; McQuilten Z; Higgins AM; Mouncey PR; Al-Beidh F; Rowan KM; Berry LR; Lorenzi E; Zarychanski R; Arabi YM; Annane D; Beane A; van Bentum-Puijk W; Bhimani Z; Bihari S; Bonten MJM; Brunkhorst FM; Buzgau A; Buxton M; Carrier M; Cheng AC; Cove M; Detry MA; Estcourt LJ; Fitzgerald M; Girard TD; Goligher EC; Goossens H; Haniffa R; Hills T; Huang DT; Horvat CM; Hunt BJ; Ichihara N; Lamontagne F; Leavis HL; Linstrum KM; Litton E; Marshall JC; McAuley DF; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Morpeth SC; Murthy S; Neal MD; Nichol AD; Parke RL; Parker JC; Reyes LF; Saito H; Santos MS; Saunders CT; Serpa-Neto A; Seymour CW; Shankar-Hari M; Singh V; Tolppa T; Turgeon AF; Turner AM; van de Veerdonk FL; Green C; Lewis RJ; Angus DC; McArthur CJ; Berry S; Derde LPG; Webb SA; Gordon AC
JAMA; 2022 Apr; 327(13):1247-1259. PubMed ID: 35315874
[TBL] [Abstract] [Full Text] [Related]
11. Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclax.
Kapadia B; Shetty AC; Bollino D; Bhandary B; Lapidus RG; Mahmood K; Mahurkar A; Gartenhaus RB; Eckert RL; Emadi A
Exp Hematol; 2022 Apr; 108():55-63. PubMed ID: 35104581
[TBL] [Abstract] [Full Text] [Related]
12. Targeting the BMP Pathway in Prostate cancer Induced bone Disease.
Straign DM; Ihle CL; Provera MD; Owens P
Front Endocrinol (Lausanne); 2021; 12():769316. PubMed ID: 34956082
[TBL] [Abstract] [Full Text] [Related]
13. capecitabine Can Induce T Cell Apoptosis: A Potential Immunosuppressive Agent With Anti-cancer Effect.
Zhang S; Wang Z; Fan S; Liu T; Yoshida S; Yang S; Liu L; Hou W; Cao L; Wang J; Song Z; Li S; Zhang S; Wang H; Li J; Zheng H; Shen Z
Front Immunol; 2021; 12():737849. PubMed ID: 34557199
[TBL] [Abstract] [Full Text] [Related]
14. Intraosseous Injection of Calcium Phosphate Polymer-Induced Liquid Precursor Increases bone Density and Improves Early Implant Osseointegration in Ovariectomized Rats.
Zhou Y; Hu Z; Ge M; Jin W; Tang R; Li Q; Xu W; Shi J; Xie Z
Int J Nanomedicine; 2021; 16():6217-6229. PubMed ID: 34531654
[TBL] [Abstract] [Full Text] [Related]
15. Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
Gaspar N; Venkatramani R; Hecker-Nolting S; Melcon SG; Locatelli F; Bautista F; Longhi A; Lervat C; Entz-Werle N; Casanova M; Aerts I; Strauss SJ; Thebaud E; Morland B; Nieto AC; Marec-Berard P; Gambart M; Rossig C; Okpara CE; He C; Dutta L; Campbell-Hewson Q
Lancet Oncol; 2021 Sep; 22(9):1312-1321. PubMed ID: 34416158
[TBL] [Abstract] [Full Text] [Related]
16. The suitability of scanning electron microscopy in the evaluation of bone structure surfaces and selection of alloplastic materials for facial skeletal reconstruction.
Job K; Składzień J
Otolaryngol Pol; 2020 Dec; 75(4):14-19. PubMed ID: 34344840
[TBL] [Abstract] [Full Text] [Related]
17. The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia.
Wellbrock J; Behrmann L; Muschhammer J; Modemann F; Khoury K; Brauneck F; Bokemeyer C; Campeau E; Fiedler W
Ann Hematol; 2021 Dec; 100(12):2933-2941. PubMed ID: 34333666
[TBL] [Abstract] [Full Text] [Related]
18. Clinical, Radiographic, Pathologic Characterization and Survival Outcomes of Nuclear Protein of the Testis Carcinoma.
Virarkar M; Mallery M; Saleh M; Ramani NS; Morani AC; Bhosale P
J Comput Assist Tomogr; 2021 May-Jun 01; 45(3):431-441. PubMed ID: 34297512
[TBL] [Abstract] [Full Text] [Related]
19. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-cap randomized controlled trial.
Arabi YM; Gordon AC; Derde LPG; Nichol AD; Murthy S; Beidh FA; Annane D; Swaidan LA; Beane A; Beasley R; Berry LR; Bhimani Z; Bonten MJM; Bradbury CA; Brunkhorst FM; Buxton M; Buzgau A; Cheng A; De Jong M; Detry MA; Duffy EJ; Estcourt LJ; Fitzgerald M; Fowler R; Girard TD; Goligher EC; Goossens H; Haniffa R; Higgins AM; Hills TE; Horvat CM; Huang DT; King AJ; Lamontagne F; Lawler PR; Lewis R; Linstrum K; Litton E; Lorenzi E; Malakouti S; McAuley DF; McGlothlin A; Mcguinness S; McVerry BJ; Montgomery SK; Morpeth SC; Mouncey PR; Orr K; Parke R; Parker JC; Patanwala AE; Rowan KM; Santos MS; Saunders CT; Seymour CW; Shankar-Hari M; Tong SYC; Turgeon AF; Turner AM; Van de Veerdonk FL; Zarychanski R; Green C; Berry S; Marshall JC; McArthur C; Angus DC; Webb SA;
Intensive Care Med; 2021 Aug; 47(8):867-886. PubMed ID: 34251506
[TBL] [Abstract] [Full Text] [Related]
20. The targetable nanoparticle BAF312@cRGD-cap-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
[TBL] [Abstract] [Full Text] [Related]
[Next]
